Cardiac troponin I elevation and overall survival among cancer patients receiving investigational compounds during phase I trials.
about
Cardiac troponin I elevation and overall survival among cancer patients receiving investigational compounds during phase I trials.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Cardiac troponin I elevation a ...... mpounds during phase I trials.
@en
Cardiac troponin I elevation a ...... mpounds during phase I trials.
@nl
type
label
Cardiac troponin I elevation a ...... mpounds during phase I trials.
@en
Cardiac troponin I elevation a ...... mpounds during phase I trials.
@nl
prefLabel
Cardiac troponin I elevation a ...... mpounds during phase I trials.
@en
Cardiac troponin I elevation a ...... mpounds during phase I trials.
@nl
P2093
P50
P1476
Cardiac troponin I elevation a ...... mpounds during phase I trials.
@en
P2093
Anas Gazzah
Andrea Varga
Antoine Hollebecque
Ariel Cohen
Christophe Massard
Franck Boccara
Frederic Troallen
Laurie Soulat-Dufour
Rastislav Bahleda
Sophie Postel-Vinay
P304
P356
10.1016/J.IJCARD.2016.04.010
P407
P577
2016-04-07T00:00:00Z